# Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

> **NCT05103735** · — · COMPLETED · sponsor: **Azienda Sanitaria-Universitaria Integrata di Udine** · enrollment: 170 (actual)

## Conditions studied

- Craniotomy
- Seizures
- Dexmedetomidine
- Propofol
- Remifentanil
- Cerebral Tumor
- Neurophysiology

## Interventions

- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05103735
- **Lead sponsor:** Azienda Sanitaria-Universitaria Integrata di Udine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2021-10-10
- **Final completion:** 2021-10-11
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103735, "Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05103735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*